Subscribe
  
IPQ Inside the global regulatory dialogue

UK MHRA’s Compliance Management Upgrade Includes “Risk Intelligence IT System” for Drug Inspection Targeting

May 24th, 2014

Please Log in to print the full article

U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) is creating a comprehensive “Risk Intelligence IT System” for determining where to deploy its inspection resources that captures and analyzes a wide variety of inputs from industry, public, and agency information sources.

Data feeding into the revamped risk-based inspection planning system will include: ● agency inspection reports ● network market intelligence ● media reports – for example, dramatic shifts in company share prices ● information from whistle-blowers, and ● information from other government regulatory agencies such as FDA or Australia’s TGA.

The new system complements a broader MHRA effort that is aimed at improving its interactions and communication with industry and getting a better handle on where compliance and drug shortage risks are located before they manifest themselves.

At a PharmaLink conference in March in Cincinnati, Ohio, co-sponsored by FDA and Xavier University, MHRA GMDP Inspections Group Manager Mark Birse reviewed his agency’s initiatives in these areas.

[The story continues for subscribers beginning on page 2.  Nonsubscribers can purchase the story for $195 by contacting Wayne Rhodes ([email protected]).  For subscription/license information, click here.]

Pages: 1 2

    ©2021 IPQ Publications